Prognostic value of tumor-infiltrating lymphocytes for patients with completely resected stage IIIA(N2) non-small cell lung cancer | Zendy

Wen Feng | Zendy; Yuan Li | Zendy; Lei Shen | Zendy; Xu-Wei Cai | Zendy; ZhengFei Zhu | Zendy; Jian-Hua Chang | Zendy; Jia-Qing Xiang | Zendy; Ya-Wei Zhang | Zendy; Haiquan Chen | Zendy; Xiaolong Fu | Zendy

Open Access

Prognostic value of tumor-infiltrating lymphocytes for patients with completely resected stage IIIA(N2) non-small cell lung cancer

Author(s) -

Wen Feng,

Yuan Li,

Lei Shen,

Xu-Wei Cai,

ZhengFei Zhu,

Jian-Hua Chang,

Jia-Qing Xiang,

Ya-Wei Zhang,

Haiquan Chen,

Xiaolong Fu

Publication year - 2016

Publication title -

oncotarget

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.373

H-Index - 127

ISSN - 1949-2553

DOI - 10.18632/oncotarget.6979

Subject(s) - medicine , lung cancer , oncology , stage (stratigraphy) , tumor infiltrating lymphocytes , cancer , immunotherapy , paleontology , biology

The patient prognosis after complete resection for pathologic stage IIIA(N2) non-small cell lung cancer (NSCLC) remains a significant concern. The clinical relevance of the host immune response to NSCLC has yet to be established. We aimed to investigate the prognostic value of tumor-infiltrating lymphocytes (TILs) in a uniform cohort of patients with completely resected stage IIIA(N2) NSCLC.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research